期刊文献+

荧光原位杂交技术检测多发性骨髓瘤细胞遗传学异常及其意义 被引量:1

The significance and cytogenetic abnormalities about multiple myelom detecting by fluorescence in situ hybridization
暂未订购
导出
摘要 目的探讨多发性骨髓瘤(MM)常见染色体异常。方法结合1q21/RB1、D13S319/p53、IGH一组DNA特异性探针和荧光原位杂交(FISH)技术检测MM患者13q14缺失、+1、p53缺失以及IgH基因重排的发生率。结果22例MM患者中,13q14缺失7例(31.8%),其中D13S319、RB1探针同时检出4例13号染色体异常;IgH基因重排6例(27.2%);+113例(59.1%);p53基因缺失4例(18.1%)。不同免疫球蛋白类型的D13S319缺失率差异有统计学意义(P<0.05)。结论13q14缺失、IgH基因重排及+1在MM中发生率较高,FISH技术检测分子遗传学异常敏感度高,应作为MM的常规检查方法。 Objective To explore the chromosome abnormalities in multiple myeloma (MM). Methods To combine a panel probes of LSI 1q21/RB1 , D13S319/p53, IGH and interphase flurorescenee in situ hybridization (FISH) were used to detect the 13q14 deletion,trisomy 1,p53 deletion and IgH gene rearrangements. Results Among 22 MM patients, 13q14 deletion was observed in 7(31.8% )cases, the probe of D13S319 and RB1 were simultaneously 4 cases 13q14 deletion; 14q32 translocation was observed in 6(27.2% )cases; trisomy 1 was observed in 13 (59. 1% )cases; p53 deletion was observed in 4 (18. 1% ) cases;different types of immunoglobulin were associated with D13s319 deletion(P 〈 0. 05). Conclusion The incidence of 13q14 deletion,lgH gene trans- location and trisomy 1 in multiple myeloma are high. FISH technique is a highly sensitive technique at detecting mo- lecular cytogenetic aberrations and shall be used in the routine evaluation of MM.
出处 《安徽医科大学学报》 CAS 北大核心 2009年第6期722-725,共4页 Acta Universitatis Medicinalis Anhui
基金 国家卫生部科研基金(编号:WKJ2007-3-001)
关键词 多发性骨髓瘤/遗传学 原位杂交 荧光 染色体畸变 multiple myeloma/genetics in situ hybridization, flurorescenee chromosome aberrations
  • 相关文献

参考文献17

  • 1Yuregir O O, Sahin F l, Yilmaz Z, et al. Fluorescence in situ hybridizati studies in multiple myeloma [ J ]. Hematology, 2009, 14 (2) :90 -4.
  • 2Chen L J ,Li J Y ,Xu W,et at. Molecular cytogenetic aberrations in patients with multiple mveloma studied by interphase fluorescence in situ hybridization[J]. Exp Oncol,2007,29 ( 6 ) : 116 - 20.
  • 3张之南.血液病诊断及疗效标[M].2版.北京:科学出版社,1998:1.
  • 4李建勇,潘金兰,葛峥,沈云峰,仇海荣,吴冠宇,吴亚芳,肖冰,薛永权.间期荧光原位杂交技术检测多发性骨髓瘤3号染色体三体[J].临床检验杂志,2006,24(1):56-57. 被引量:4
  • 5刘淑艳,李建勇,陈丽娟,黄金文,潘金兰,仇海荣,沈云峰,徐卫,薛永权.多发性骨髓瘤分子细胞遗传学异常的研究[J].中华血液学杂志,2007,28(4):223-226. 被引量:8
  • 6Jagannath S, Richardson P G, Sonneveld P, et al. Bortezomib appears to overcome the poor prognosis conferred by chromosome 13 deletion in phase 2 and 3 trials[J]. Leukemia,2007,21 ( 1 ) :151 -7.
  • 7Shaughnessy J ,Tian E,Sawyer J,et al. High incidence of chromosome 13 deletion in multiple myeloma detected by muhiprobe interphase FISH [ J ]. Blood,2000,96 (4) : 1505.
  • 8Fonseea R, Oken M M, Harringlon D, et al. Deletions of chromosome 13 in muhiple myeloma identified by interphase FISH usually denote large deletions of the q ann or monosomy [J]. Leukemia, 2001,15(6) :981 -6.
  • 9Facon T, Avet-Loiseau H, Guillerm G ,et al. Chromosome 13 abnormaliies identified by FISH analysis and serumβ2-microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapy [J]. Blood ,2001,97 ( 6 ) : 1561 - 77.
  • 10Avet-Loiseau H, Facon T,Grosbois B, et al. Oncogenesis of multipte myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed,but correlate with natural history immunological features, and clinical presentation [J]. Blood, 2002,99 ( 6 ) : 2185 -91.

二级参考文献21

  • 1刘淑艳,薛永权,黄金文.荧光原位杂交技术在多发性骨髓瘤染色体异常检测中的应用[J].国外医学(输血及血液学分册),2005,28(5):432-435. 被引量:3
  • 2张之南.血液病诊断与疗效标准[M].北京:科学技术出版社,1998.304.
  • 3[1]Calasanz M J,Cigudosa J C,Odero M D,et al.Cytogenetics analysis of 280 patients with multiple myeloma and related disorder:primary breakpoints and clinical correlations[J].Genes Chromosom Cancer,1997,18(2):84-93.
  • 4[2]Seong C,Delasalle K,Hayes K,et al.Prognostic value of cytogenetics in multiple myeloma[J].Br J Haematol,1998,101 (1):189-194.
  • 5[3]Dubinsky R,Amiel A,Manor Y,et al.Fluorescence in situ hybridization (FISH) for retrospective detection of trisomies 3 and 7 in multiple myeloma[J].Cancer Genet C ytogenet,1995,83 (2):115-118.
  • 6[6]Mitelman F.Aninternational system for human cytogenetic nomenclature[M].Basel:Karger S,1995.
  • 7[8]Drach J,Schuster J,Nowotny H,et al.Multiple myeloma:High incidence of chromosomal aneuploidy as detected by interphase fluorescence in situ hybridization[J].Cancer Res,1995,55 (17):3854-3859.
  • 8[9]Perez-Simon J A,Garcia-Sanz R,Tabernero M D,et al.Prognostic value of numerical chromosome aberrations in multiple myeloma:a FISH analysis of 15 different chromosomes[J].Blood,1998,91 (9):3366-3371.
  • 9Fiserova A, Hajek R, Holubova V, et al. Detection of 13 q abnormalities in multiple myeloma using immunomagnetically selected plasma cells. Neoplasma, 2002,49:300-306.
  • 10Greipp PR, San Miguel J, Dude BG, et al. International staging system for multiple myeloma. J Clin Oncol, 2005, 23:3412-3420.

共引文献11

同被引文献5

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部